8-KItem 2.02 · Results of OperationsItem 2.05 · Exit/Disposal CostsItem 8.01 · Other EventsItem 9.01 · Financial Statements
Viatris Inc (VTRS)

Viatris filed an 8‑K (Item 9.01) on Feb 26, 2026: Exhibit 99.1 — press release with Q4 & FY2025 financial…

Filed with the SEC on · Summarized by InvestorsBot

Viatris filed an 8‑K (Item 9.01) on Feb 26, 2026: Exhibit 99.1 — press release with Q4 & FY2025 financial results (period ended Dec 31, 2025); Exhibit 104 — Inline XBRL cover page. Signed by CFO Theodora Mistras. $VTRS 📄📊 #Earnings #8K #Healthcare

Investor alert: $VTRS 8‑K includes the Q4 & FY2025 results press release (Ex.99.1) and machine‑readable Inline XBRL (Ex.104) for detailed financial data — review for revenue, EPS and guidance info. Filed Feb 26, 2026. 🧾🔍 #Earnings #Investors

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from Viatris Inc

Viatris to host conference call & webcast today 8:30 AM ET (2/26/2026) to review Q4 & FY2025 results.

8-K · February 26, 2026

Viatris ($VTRS) on Feb 26, 2026 announced EWSR results: global workforce reduction of up to ~10%;…

8-K · February 26, 2026

Viatris ($VTRS) on Feb 26, 2026 issued a press release reporting financial results for the period ended…

8-K · February 26, 2026

Viatris ($VTRS) announced CLO Brian Roman will cease serving as CLO effective Feb 9, 2026; he’ll remain an…

8-K · February 3, 2026